Xencor Inc (XNCR)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 4.56 | 3.88 | 4.11 | 3.75 | 5.44 | 3.56 | 3.20 | 4.05 | 3.22 | 4.40 | 5.21 | 4.62 | 3.84 | 2.46 | 2.94 | 2.85 | 2.72 | 3.07 | 2.96 | 4.71 | |
Number of days of payables | days | 80.00 | 94.10 | 88.82 | 97.27 | 67.08 | 102.58 | 114.01 | 90.18 | 113.22 | 82.98 | 70.11 | 79.02 | 95.04 | 148.43 | 124.32 | 128.07 | 134.33 | 119.08 | 123.31 | 77.53 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 4.56
= 80.00
Based on the data provided, it appears that the number of days of payables for Xencor Inc has not been disclosed for each quarter of the periods listed. Without this specific information, it is challenging to assess the company's payment practices and efficiency in settling its obligations to suppliers. Monitoring the number of days of payables can provide insights into the company's liquidity management and relationships with suppliers. Investors and analysts may benefit from additional data to better understand Xencor Inc's payables turnover and working capital management.
Peer comparison
Dec 31, 2023
Company name
Symbol
Number of days of payables
Xencor Inc
XNCR
80.00
Abbott Laboratories
ABT
49.95
AbbVie Inc
ABBV
36.53
Alkermes Plc
ALKS
19.63
Amphastar P
AMPH
31.66
ANI Pharmaceuticals Inc
ANIP
33.22
Arcus Biosciences Inc
RCUS
50.86
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
42.27
Catalent Inc
CTLT
39.59
Catalyst Pharmaceuticals Inc
CPRX
26.83